aawh

Weak Michigan Cannabis Sales Again in July – New Cannabis Ventures

Published

6 months ago

August 17, 2025

admin

Weak Michigan Cannabis Sales Again in July – New Cannabis Ventures

August 14, 2025, at 12 o’clock. At 49

Michigan July’s hemp sale He fell a year ago, as they settled by 5.2%, which reached a little on the basis of one day. The sale of $ 274.7 million decreased by 4.5% compared to the previous year.

The Michigan Caneppe Regulatory Agency is divided into medical and adults, medical sales by 64.3% a year ago, reaching $ 0.5 million, increased by 4.3% compared to the middle year, increased by 5.2%.

The state violates the sale by category and provides pricing details by category as adult usage and medical.

Adult usage

Medical Medical

As the supply continues to expand, the pricing of flowers has fallen sharply to adults. In July, $ 997 a pound of the average price of a pound was 0.3%, a record low and decreased by 21.8% a year ago.

Michigan’s hemp sale from 2021 reaches 1.79 billion, from 2022 to $ 2.29 billion and 33.3% to $ 3.06 billion.

Based on the Houston, Alan cries out his experience as the founder of the online community 420 InvestorThe first and still the biggest decent diligent platform focused on the shares sold in the cannabis industry. Alan continues to find new ways to connect industry and facilitate its sustainable growth in the Canepuni community. Approximately New hemp enterprisesHe is responsible for content development and strategic alliances. Until the early 2013 focuses on the cannabis industry, Alan, who began his career in Wall Street, worked as more than two decades of research and portfolio. Article 650 of the Article 650 published in 2007 Looking for alphaWhere he has 70,000 followers, Alan is a frequent speaker for industry conferences and a Frequent source The media, including NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Ration | Facebook | Connection | Email

Related Topics:Cannabis July Michigan Sales Ventures Weak

Up Next

Cannabis Investors Should Consider REITs – New Cannabis Ventures

4Front

Illinois Provides Another Cannabis Update – New Cannabis Ventures

Published

5 days ago

February 1, 2026

admin

Illinois Cannabis Data Change Suggests Much Lower Sales – New Cannabis Ventures

February 1, 2026 at 3:27 p.m

Illinois released sales figures for two months on Friday. The last time it released the data in November, the state did a major review of historical sales after a long delay, and it was updated to October. The previous report was for Cannabis for adults in May. The November document explained that the lack of data was due to the Metrc transition. “Sales tracking features in Metrc help retailers more accurately and reliably report actual sales, including all discounts and promotions at checkout. A careful review of past data shows that some initial discount prices were collected in previous months.” Here is the updated data until the end of 2025.

Statewide adult cannabis sales rose 5.6% sequentially to $116.6 million in December, up 2.2% on the day. Year-on-year growth was -23.9%, a slight improvement from November’s -26.1% growth. Here is a chart of adult sales over time:

After growing 106% in 2021, 13% in 2022 and 5% in 2023, annual sales for adults are set to grow 5.4% to $1.72 billion in 2024. In 2025, they decreased by 12.5% to $1.51 billion, which was lower than the total in 2022.

There hasn’t been an update from the state on medical cannabis in a while. The state exempts the sale separately from its medical plan, and April issue showed that sales fell 1.6% sequentially to $19.7 million, down 13.2% year over year.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El

In this article.

4 Front, Aaaaaah, rise to health, ayr health, AYRWF:, Cannabist, cbst:, cbstf:, cl:, Cresco Labs, CRLBF:, treatment, Curaleaf:, curly, flight, ffntf:, Green Thumb Industries, gtbif:, gti:, Illinois, YOU:, jusf, jushi, embodied, mrmd:, Planet 13:, plnh, PLTH:, summer, WITH:, vrnoff:

aawh

Cannabis Stocks Rally Begin 2026 Badly – New Cannabis Ventures

Published

7 days ago

January 30, 2026

admin

Cannabis Stocks Rocketed Higher in August – New Cannabis Ventures

Hemp stocks, as measured by the Global Hemp Stock Index, were quite volatile in 2024 and then again in 2025 as well. Although the index rose in December, it fell on the year. In January, the indicator decreased by 10.6%, reaching 5.89.

After collapsing 21.8% in late 2024 to 6.88 in Q4, the index fell heavily in Q1 and then marginally in Q2. The global hemp stock index, which now has 27 members, gained 53.0% in the third quarter but fell 14.2% in the fourth quarter, down 4.2% for the full year.

Since its peak in February 2021, the global hemp stock index is down 93.6% from a closing high of 92.48.

The 3 strongest names in January, each an MSO, were all up more than 4%;

January’s 3 weakest names are all down more than 26%;

Akanda (NASDAQ: WILL). -44.0%
iPower: (NASDAQ: IPW). -42.0%
RHYTHM (Name: RYM). -26.0%

We will summarize the performance of the index again in a month. In April, we historically combined the two articles, and we update here the other indexes that New Cannabis Ventures continues to maintain: the American Cannabis Operator Index, the Ancillary Cannabis Index, and the Canadian Cannabis LP Index.

American Hemp Operator Index

The ACOI sank in January, falling 12.5% to 11.53. In 2025, it increased by 57.7%, reaching 13.18. The large AdvisorShares Pure US Cannabis ETF ( MSOS ) fell 14.6% in January.

The strongest stock in January was Glass House Brands, which rose 4.0%. The weakest, Trulieve (OTC: TCNNF ), fell 20.5%.

The index will have nine members in February with the removals of Ascend Wellness (OTC: AAWH ) and Grown Rogue ( GRUSF ).

Auxiliary cannabis index

Ancillary commodities lost 5.9% in January as the index fell to 10.44. In 2025, the indicator decreased by 19.5%, reaching 11.09.

January’s strongest stock was Turning Point Brands, which rose 21.8%. The weakest iPower fell by 42.0%.

In February, the index will have the same ten members.

Canadian Hemp LP Index

Canadian LPs fell 4.9% in January as the index fell to 56.13. In 2025, the indicator increased by 17.8%, reaching 59.01.

Canada’s strongest LP in January was Simply Solventless Concentrates (TSXV: HASH ), up 28.6%. Tilray Brands (TSX: TLRY ) was the weakest, down 18.0%.

In February, the index will have the same thirteen members.

In this article.

Aaaaaah, WILL, Akanda, rise to health, blue, glass house brands, grown up bastard, grosf, HASH:, capacity, ipw:, power, rhythm, Scotts Miracle-Gro, Simply unsolvable, smg, tcnnf:, Tilray brands, TLRY:, TPB:, Trulul, to truly believe, Revolving brands

aawh

Michigan Cannabis Sales Were Soft in December – New Cannabis Ventures

Published

3 weeks ago

January 14, 2026

admin

Michigan Cannabis Sales Were Soft in December – New Cannabis Ventures

On January 14, 2026 at 5:06 pm

Michigan hemp sales for the month of December increased from a year ago as they rose 3.8% sequentially, which was +0.5% on a daily basis. At $269.7 million, sales increased by 1.6 percent compared to last year.

The Michigan Cannabis Regulatory Agency breaks down sales by medical and adult use, with medical sales down 50.2% year-over-year to $0.4 million, up 10.8% sequentially, and adult-use sales up 1.7% year-over-year to $269.3 million, up 3.8% sequentially.

The state breaks down sales by category and provides pricing details by category for both medical and adult;